Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study
<p>Abstract</p> <p>Background</p> <p>Minocycline is a tetracycline antibiotic that has been shown to attenuate central nervous system (CNS) lentivirus infection, immune activation, and brain injury in model systems. To initiate assessment of minocycline as an adjuvant t...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-05-01
|
| Series: | AIDS Research and Therapy |
| Online Access: | http://www.aidsrestherapy.com/content/8/1/17 |
| _version_ | 1828352165978046464 |
|---|---|
| author | Fuchs Dietmar Lee Evelyn Spudich Serena S Ho Emily L Sinclair Elizabeth Price Richard W |
| author_facet | Fuchs Dietmar Lee Evelyn Spudich Serena S Ho Emily L Sinclair Elizabeth Price Richard W |
| author_sort | Fuchs Dietmar |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Minocycline is a tetracycline antibiotic that has been shown to attenuate central nervous system (CNS) lentivirus infection, immune activation, and brain injury in model systems. To initiate assessment of minocycline as an adjuvant therapy in human CNS HIV infection, we conducted an open-labelled pilot study of its effects on cerebrospinal fluid (CSF) and blood biomarkers of infection and immune responses in 7 viremic subjects not taking antiretroviral therapy.</p> <p>Results</p> <p>There were no discernable effects of minocycline on CSF or blood HIV-1 RNA, or biomarkers of immune activation and inflammation including: CSF and blood neopterin, CSF CCL2, CSF white blood cell count, and expression of cell-surface activation markers on CSF and blood T lymphocytes and monocytes.</p> <p>Conclusions</p> <p>This pilot study of biological responses to minocycline suggests little potential for its use as adjunctive antiviral or immunomodulating therapy in chronic untreated HIV infection.</p> |
| first_indexed | 2024-04-14T01:51:02Z |
| format | Article |
| id | doaj.art-c079ba6e74154d2f9b3ecb795d0d2f24 |
| institution | Directory Open Access Journal |
| issn | 1742-6405 |
| language | English |
| last_indexed | 2024-04-14T01:51:02Z |
| publishDate | 2011-05-01 |
| publisher | BMC |
| record_format | Article |
| series | AIDS Research and Therapy |
| spelling | doaj.art-c079ba6e74154d2f9b3ecb795d0d2f242022-12-22T02:19:22ZengBMCAIDS Research and Therapy1742-64052011-05-01811710.1186/1742-6405-8-17Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot studyFuchs DietmarLee EvelynSpudich Serena SHo Emily LSinclair ElizabethPrice Richard W<p>Abstract</p> <p>Background</p> <p>Minocycline is a tetracycline antibiotic that has been shown to attenuate central nervous system (CNS) lentivirus infection, immune activation, and brain injury in model systems. To initiate assessment of minocycline as an adjuvant therapy in human CNS HIV infection, we conducted an open-labelled pilot study of its effects on cerebrospinal fluid (CSF) and blood biomarkers of infection and immune responses in 7 viremic subjects not taking antiretroviral therapy.</p> <p>Results</p> <p>There were no discernable effects of minocycline on CSF or blood HIV-1 RNA, or biomarkers of immune activation and inflammation including: CSF and blood neopterin, CSF CCL2, CSF white blood cell count, and expression of cell-surface activation markers on CSF and blood T lymphocytes and monocytes.</p> <p>Conclusions</p> <p>This pilot study of biological responses to minocycline suggests little potential for its use as adjunctive antiviral or immunomodulating therapy in chronic untreated HIV infection.</p>http://www.aidsrestherapy.com/content/8/1/17 |
| spellingShingle | Fuchs Dietmar Lee Evelyn Spudich Serena S Ho Emily L Sinclair Elizabeth Price Richard W Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study AIDS Research and Therapy |
| title | Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study |
| title_full | Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study |
| title_fullStr | Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study |
| title_full_unstemmed | Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study |
| title_short | Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study |
| title_sort | minocycline fails to modulate cerebrospinal fluid hiv infection or immune activation in chronic untreated hiv 1 infection results of a pilot study |
| url | http://www.aidsrestherapy.com/content/8/1/17 |
| work_keys_str_mv | AT fuchsdietmar minocyclinefailstomodulatecerebrospinalfluidhivinfectionorimmuneactivationinchronicuntreatedhiv1infectionresultsofapilotstudy AT leeevelyn minocyclinefailstomodulatecerebrospinalfluidhivinfectionorimmuneactivationinchronicuntreatedhiv1infectionresultsofapilotstudy AT spudichserenas minocyclinefailstomodulatecerebrospinalfluidhivinfectionorimmuneactivationinchronicuntreatedhiv1infectionresultsofapilotstudy AT hoemilyl minocyclinefailstomodulatecerebrospinalfluidhivinfectionorimmuneactivationinchronicuntreatedhiv1infectionresultsofapilotstudy AT sinclairelizabeth minocyclinefailstomodulatecerebrospinalfluidhivinfectionorimmuneactivationinchronicuntreatedhiv1infectionresultsofapilotstudy AT pricerichardw minocyclinefailstomodulatecerebrospinalfluidhivinfectionorimmuneactivationinchronicuntreatedhiv1infectionresultsofapilotstudy |